MyFinsight
Home
Blog
About
Contact
nvax: the balance sheet
Download
Download image
Assets held for sale
$107,663K
Prepaid expenses and
other current assets
$45,532K
Inventory
$13,511K
Accounts receivable
$34,174K
Restricted cash
$10,816K
Marketable securities
$494,871K
Cash and cash
equivalents
$268,023K
Other non-current
assets
$19,226K
Goodwill
$113,080K
Right of use asset, net
$23,873K
Property and equipment,
net
$49,120K
Total current assets
$974,590K
Total assets
$1,179,889K
Accumulated other
comprehensive loss
-$1,745K
Treasury stock, cost
basis, 2,347,128...
$102,663K
Accumulated deficit
-$4,585,675K
Total liabilities and
stockholders deficit
$1,179,889K
Total stockholders
deficit
-$156,672K
Additional paid-in capital
$4,531,763K
Common stock, 0.01 par
value, 600,000,000...
$1,648K
Total liabilities
$1,336,561K
Other non-current
liabilities
$263,483K
Non-current finance lease
liabilities
$2,269K
Convertible notes payable
$243,835K
Deferred revenue
$397,105K
Total current
liabilities
$429,869K
Liabilities held for sale
$51,435K
Other current
liabilities
$138,334K
Current portion of
finance lease...
$5,036K
Deferred revenue
$104,251K
Accrued expenses
$115,586K
Accounts payable
$15,227K
Back
Back
Balance Sheet
source: myfinsight.com
NOVAVAX INC (NVAX)
NOVAVAX INC (NVAX)